Summit Therapeutics trades 6,211 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
Summit Therapeutics trades 11,882 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
Summit Therapeutics trades 27,676 contracts. The company has the following event: Summit Conference Call and Live Webcast (Ivonescimab updates including ASCO data) on Jun 1, 2026.
Summit Therapeutics trades 5,892 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
